C. Ola Landgren on Treating Smoldering Multiple Myeloma

Article

C. Ola Landgren, MD, PhD, hematologic oncologist, chief, Myeloma Service, Memorial Sloan Kettering Cancer Center, discusses treating smoldering multiple myeloma.

C. Ola Landgren, MD, PhD, hematologic oncologist, chief, Myeloma Service, Memorial Sloan Kettering Cancer Center, discusses treating smoldering multiple myeloma.

Smoldering multiple myeloma is an asymptomatic early precursor to multiple myeloma. Current guidelines recommend that patients with smoldering multiple myeloma be monitored, but studies have shown that early treatment can lead to rapid, durable responses, Landgren says.

Landgren adds that patients with high-risk smoldering multiple myeloma should be treated by myeloma specialists and consider enrolling in a clinical trial to delay or potentially prevent the development of multiple myeloma.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.